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Apical sodium-dependent
bile acid transporter
ASBTr expressed in the proximal small intestine but not in the distal ileum, maintains
proximal–distal distinctions by multiple processes involving gene repression, gene activation, and cell fate
determination. Friend of GATA (FOG) is an evolutionarily conserved family of cofactors whose members
physically associate with GATA factors and mediate GATA-regulated repression in multiple tissues. Using a
novel, inducible, intestine-speciﬁc Gata4 knock-in model in mice, in which wild-type GATA4 is speciﬁcally
inactivated in the small intestine, but a GATA4 mutant that does not bind FOG cofactors (GATA4ki) continues
to be expressed, we found that ileal-speciﬁc genes were signiﬁcantly induced in the proximal small intestine
(Pb0.01); in contrast, genes restricted to proximal small intestine and cell lineage markers were unaffected,
indicating that GATA4–FOG interactions contribute speciﬁcally to the repression function of GATA4 within
this organ. Fog1mRNA displayed a proximal–distal pattern that parallels that of Gata4, and FOG1 protein was
co-expressed with GATA4 in intestinal epithelial cells, implicating FOG1 as the likely mediator of GATA4
function in the small intestine. Our data are the ﬁrst to indicate FOG function and expression in the
mammalian small intestine.
© 2008 Elsevier Inc. All rights reserved.IntroductionThe mammalian small intestine is lined by a highly specialized
epithelium that displays a wide ranging, yet tightly regulated
functional diversity along its cephalo–caudal axis (Gordon et al.,
1992). This functional diversity is linked to a continuous renewal
process in which stem cells located at or near the base of crypts
produce transit amplifying cells that ultimately differentiate into four
principal cell types. Absorptive enterocytes, which constitute the
majority of intestinal epithelial cells, enteroendocrine cells, and
goblet cells migrate up the villi and are shed into the intestinal lumen
every 3 to 5 days, whereas Paneth cells reside at the base of crypts and
turn over at a slower rate. Speciﬁc absorptive enterocyte genes that
encode proteins that mediate absorption of bile salts are localized to
the distal ileum, including the apical sodium-dependent bile acid
transporter (ASBT) (Shneider, 2001) and ileal lipid binding proteinildren's Hospital Boston, 300
730 0498.
.edu (S.D. Krasinski).
l rights reserved.(ILBP) (Crossman et al., 1994). Proteins responsible for the terminal
digestion and absorption of most nutrients are localized to jejunum
and proximal ileum, as exempliﬁed by lactase-phlorizin hydrolase
(LPH) (Krasinski et al., 1997) and liver fatty acid binding protein
(FABP1) (Simon et al., 1993). Goblet cells are more numerous in distal
small intestine (Specian and Oliver, 1991), and enteroendocrine
subpopulations display a functional diversity characterized by the
regional segregation of hormones that activate (e.g. cholecystokinin,
CCK) or repress (e.g. peptide YY, PYY) gastrointestinal processes
(Schonhoff et al., 2004). Maintenance of a dynamic diversity in gene
expression and cell fate allocation along the cephalo–caudal axis is
necessary for the normal functioning of the small intestine.
Recently, we found that GATA4 is a key regulator of regional gene
expression and cell fate allocation in the adult mouse small intestine
(Bosse et al., 2006a). GATA4 is a member of a conserved family of
transcription factors that contain a pair of zinc ﬁngers that mediate
binding to their consensus DNA sequence, WGATAR, in the regulatory
region of target genes (Molkentin, 2000). In the small intestine of adult
rodents and humans, GATA4 is expressed at high levels in proximal
regions, but is undetectable in distal ileum (Bosse et al., 2006a; van
Wering et al., 2004). Conditional, inducible inactivation of Gata4 in the
180 E. Beuling et al. / Developmental Biology 322 (2008) 179–189adult mouse jejunum results in a generalized transformation to an
ileal-like phenotype that is characterized by an induction of ileal-
speciﬁc genes, including Asbt and Ilbp, and attenuation of genes
restricted to proximal small intestine, including Lph and Fabp1.
Furthermore, secretory cell fate also becomes ileal-like as indicated
by a signiﬁcant increase in goblet cell number and the abundance of
themRNA forMath1, a secretory cell mediator (Yang et al., 2001), and a
trend toward an increase in Pyy mRNA and a decrease in Cck mRNA
(Bosse et al., 2006a). This novel ﬁnding establishes a fundamental
plasticity in the adult mammalian small intestine not previously
realized, and highlights multiple levels of regulation by GATA4 in this
organ involving gene repression, gene activation, and cell fate
determination. However, the precise mechanisms by which GATA4
regulates these diverse functions in the mature small intestine are
currently unknown.
Friend of GATA (FOG) is an evolutionarily conserved multi-zinc
ﬁnger cofactor family whose members physically associate with
GATA factors, and mediate GATA function in a broad array of tissues
and cell types (Cantor and Orkin, 2005). The GATA–FOG interaction is
conserved in Drosophila where the FOG homolog, U-shaped, physi-
cally associates with pannier, a GATA homolog (Haenlin et al., 1997),
indicating the fundamental importance of this interaction. Using a
split two-hybrid screen, a GATA1 mutant (GATA1ki) with a valine-to-
glycine substitution at position 205 in the N-terminal zinc ﬁnger was
identiﬁed that has attenuated binding afﬁnity for FOG cofactors, but
normal DNA binding function (Crispino et al., 1999). Gata1ki/ki miceFig. 1. In vivo mouse models. (A) Schematic representation of the different Gata4 alleles used
boxes indicate translated region. Numbers indicate exons. Red arrowheads indicate loxP sites
indicates a residual loxP site previously used to remove a neomycin cassette from the Gata4ki
Zn, zinc ﬁngers; CTD, C-terminal domain. Filled arrowheads indicate PCR primers. (B) Model
before and after tamoxifen treatment. vCre indicates the VillinCreERT2 transgene.that express GATA1ki in place of GATA1 die during embryogenesis
due to anemia caused by disrupted erythroid maturation and
megakaryocyte abnormalities (Crispino et al., 1999). This phenotype
is similar to that in Gata1−/− (Chang et al., 2002; Fujiwara et al., 1996;
Pevny et al., 1991) or Fog1−/− (Tsang et al., 1998) mice, indicating that
GATA1–FOG1 interaction is required for hematopoiesis. A FOG1
mutant that restores GATA1–FOG1 interaction rescues this pheno-
type, providing in vivo evidence that the Gata1 knock-in mutation
speciﬁcally disrupts the ability of GATA1 to bind FOG cofactors, and
that GATA1ki is otherwise functional (Cantor et al., 2002; Crispino
et al., 1999). In addition, a Gata4 knock-in model was designed with
the analogous valine-to-glycine substitution at position 217 in GATA4
(GATA4ki) that disrupts the interaction between GATA4 and FOG
cofactors (Crispino et al., 2001; Tevosian et al., 2002). Gata4ki/ki mice
show an embryonic lethal cardiac phenotype, very similar to that
found in Gata4−/− (Kuo et al., 1997; Molkentin et al., 1997) and Fog2−/−
(Svensson et al., 2000; Tevosian et al., 2000) mice, providing
evidence that GATA4–FOG2 interaction is required for cardiogenesis.
Furthermore, the Gata4ki model has revealed that GATA4–FOG
interaction is important in gonadal differentiation (Manuylov et al.,
2007; Tevosian et al., 2002) and gastric epithelial development
(Jacobsen et al., 2005).
Using a novel, inducible, intestine-speciﬁc Gata4 knock-in model in
mice, in which wild-type GATA4 is speciﬁcally inactivated in the small
intestine, but a GATA4 mutant that does not bind FOG cofactors
(GATA4ki) continues to be expressed, we found that ileal-speciﬁc genesin this study, and their protein products. Open boxes indicate untranslated region. Filled
used for excision of the GATA4 activation domains in the Gata4ﬂox allele. Blue arrowhead
allele (Crispino et al., 2001). Blue boxes indicate protein product. AD, activation domain;
s used in this study showing the Gata4 alleles in different tissue in test and control mice
181E. Beuling et al. / Developmental Biology 322 (2008) 179–189were signiﬁcantly induced in the proximal small intestine (Pb0.01), but
genes restricted to proximal small intestine and cell lineage markers
were unaffected, indicating that GATA4–FOG interactions contribute
speciﬁcally to the repression function of GATA4 within this organ. Fog1
mRNA displayed a proximal–distal pattern that parallels that of Gata4,
and FOG1 proteinwas co-expressed with GATA4 in intestinal epithelial
cells, implicating FOG1 as the likely mediator of GATA4 function in the
small intestine. These data are the ﬁrst to indicate FOG function and
expression in the mammalian small intestine.Fig. 2. GATA4-mediated repression of Asbt expression occurs in differentiated
absorptive enterocytes. Gata4ﬂox/ﬂox, VillinCreERT2-positive mice were treated with
tamoxifen for 1 day (1 day TAM) or 2 days (2 day TAM) and sacriﬁced 24 h after the last
injection. Gata4ﬂox/ﬂox mice, negative (Flox control) or positive (Gata4 mutant) for the
VillinCreERT2 transgene were treated with tamoxifen for 5 days and sacriﬁced 2 weeks
later as described (Bosse et al., 2006a). All samples were collected from the geometric
center of the small intestine (mid-jejunum). (A) Gata4 mRNA abundance, determined
by semi-quantitative RT-PCR using primers speciﬁc for exon2, reveals complete CRE-
mediated excision after only one treatment of tamoxifen. Gapdh was used as a positive
control. This ﬁnding was replicated on 3 different sets of mice. (B) AsbtmRNA is induced
within 1 day of a single dose of tamoxifen as determined by real-time RT-PCR (n=3 in
each group). RNA from jejunum of a Gata4mutant mouse was used as a calibrator. (C–J)
ASBT is induced in the microvillus membrane of enterocytes on villi 1 and 2 days after
tamoxifen treatment as determined by immunoﬂuorescence (green). Nuclei were
counterstained with DAPI (blue).Materials and methods
Mice
Mice were housed under standard conditions in the Animal
Research at Children's Hospital (ARCH) facility and provided with
food and water ad libitum. Approval was obtained from the
Institutional Animal Care and Use Committee. Four Gata4 alleles
were utilized in this study (Fig. 1A). The Gata4ﬂox allele, which
contains loxP sites ﬂanking the translational start site and the region
encoding the activation domains of GATA4, expresses wild-type
GATA4 (Pu et al., 2004). Exposure of Gata4ﬂox to the recombinase CRE
results in exon2 excision (Gata4Δex2), and the subsequent utilization of
an alternative in-frame ATG in exon3 leading to the synthesis of a
truncated, transcriptionally inactive form of GATA4 (GATA4Δex2)
devoid of its activation domains (Bosse et al., 2006a). The Gata4ki
allele encodes a mutant GATA4 (GATA4ki) that contains a single
amino acid substitution (V217G) in the N-terminal zinc ﬁnger
rendering it unable to bind speciﬁcally with FOG cofactors (Crispino
et al., 2001). The wild-type allele (Gata4wt), was also utilized in the
study. Genotyping to distinguish among each of the four Gata4 alleles
was conducted by PCR on DNA extracted from tail biopsies as
described (Bosse et al., 2006b) using primers speciﬁc for exon2 or
exon5 of Gata4 (see Fig. S1).
Two different conditional, inducible genetic mouse models were
used for this study, including a previously validated conditional Gata4
inactivation model (Bosse et al., 2006a), and a novel conditional Gata4
knock-in model (Fig. 1B). Both models were established in a
VillinCreERT2 transgenic background (el Marjou et al., 2004) in which
CRE-mediated excision of ﬂoxed Gata4 DNA occurs speciﬁcally in
intestinal and colonic epithelium after tamoxifen treatment (Bosse et
al., 2006a). Adult mice (6–8 weeks) were treated with ﬁve single
intraperitoneal injections of tamoxifen (100 μl, 10mg/ml) per day for 5
consecutive days and sacriﬁced for tissue collection 14 days after the
last injection (Bosse et al., 2006a), unless indicated otherwise. In the
Gata4 inactivation model (Fig. 1B, Model I), Gata4ﬂox/ﬂox, Villin
CreERT2-positive mice were treated with tamoxifen resulting in
exon2 deletion (Gata4Δex2) and subsequent conditionalGata4 inactiva-
tion in the intestinal epithelium (Bosse et al., 2006a). Gata4ﬂox/ﬂox,
VillinCreERT2-negative mice treated with tamoxifen were used as
controls. In the Gata4 knock-in model (Fig. 1B, Model II), Gata4ki/ﬂox
knock-inmice andGata4wt/ﬂox controls (het-controls) were established
in a VillinCreERT2 background. Before tamoxifen treatment, both
knock-in mice and het-controls produce wild-type GATA4 from at
least one allele in all GATA4 expressing tissue, including the small
intestine. After tamoxifen treatment of knock-in mice, GATA4 and
GATA4ki are expressed in all tissues that normally express GATA4,
except in the intestinal epithelium, where GATA4 from the Gata4ﬂox
allele is speciﬁcally inactivated byCRE-mediated excision, but GATA4ki
continues to be expressed from the Gata4ki allele. After tamoxifen
treatment of het-controls, GATA4 is expressed from both alleles in all
tissues that normally express GATA4, except in the intestinal
epithelium, where Gata4ﬂox is excised by CRE, but GATA4 continues
to be expressed from the Gata4wt allele. This approach creates a
conditional, inducible Gata4 knock-in model.
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RNA was isolated from heart, stomach, and small intestine using
the RNeasy kit (Qiagen) as described previously (Bosse et al., 2006a).
Intestinal segments (0.5 to 1.0 cm) were obtained from the most
proximal region adjacent to the pylorus (segment 1), the 25% mark
(segment 2), the geometric center (segment 3), the 75% mark
(segment 4), and the most distal region adjacent to the ileocecal
junction (segment 5).
Sequencing
To conﬁrm CRE-mediated excision and expression of Gata4ki,
sequencing analyses were conducted. Complementary DNA (cDNA)
was synthesized from jejunal RNA obtained from segment 3, and
the region encompassing the knock-in mutation was ampliﬁed by
PCR. The PCR product was separated on an agarose gel by electro-
phoresis, extracted using the QIAquick Gel Extraction Kit (Qiagen),
re-ampliﬁed using the same primers, and puriﬁed using ExoSap-IT
(USB Corporation). The puriﬁed PCR product was sequenced at the
Molecular Genetics Core (Children's Hospital Boston) using a nested
primer.
RT-PCR
To quantify mRNA abundances, semi-quantitative and real-time
RT-PCR were conducted as described previously (Bosse et al., 2006a).
Primer pairs (Fig. S2) were designed using Beacon Design software
(Biosoft International) and optimized. Real-time RT-PCR was carried
out using an iCycler and iQ SYBR Green Supermix (Bio-Rad). Gapdh
mRNA abundance was measured for each sample and used to
normalize the data. All data were expressed relative to a calibrator
as indicated in the ﬁgure legends.
Immunoblotting
Crude nuclear extracts were isolated from four quarters of intestine
(proximal-to-distal: I–IV) and Western analysis was conducted as
described previously (van Wering et al., 2004) using 100 μg of extract.
The membranes were blocked for 1 h at room temperature in 5%
nonfat dried milk in PBS and incubated with goat anti-FOG1 (1:1500,
Santa Cruz) with or without FOG1 blocking peptide (1:1500, Santa
Cruz) for 1 h. Membranes were stripped and re-probed using mouseFig. 3. Fog2 mRNA abundance is lower in Gata4 knock-in mice as compared to het-controls.
isolated from themid-jejunum of Gata4 knock-inmice and het-controls. Filled diamonds repr
of a het-control mouse was used as a calibrator for Gata4 and Fog1, whereas pooled RNA franti-β-actin (1:4000, Santa Cruz). Horseradish peroxidase-linked
secondary antibodies and chemiluminescence solution (Pierce West
Femto Kit) were used to visualize FOG1 or β-actin signals.
In situ hybridization
RNA probes were prepared by in vitro transcription of a partial
cDNA insert from the Fog1 library plasmid M10 subcloned into
pBluescript KS (Stratagene) (Tsang et al., 1997) using digoxigenin-
UTP (Roche Molecular Biochemicals), and T3 (antisense) or T7
(sense) polymerase as described (Katz et al., 2003). In situ
hybridization assays were conducted as described previously
(Tevosian et al., 2000).
Immunohistochemistry
Intestinal segments were ﬁxed in ice-cold 4% paraformaldehyde in
PBS for 4 h, dehydrated overnight as described (Bosse et al., 2006a),
embedded in parafﬁn, and sectioned (5 μm) in the Department of
Pathology at Children's Hospital Boston. After deparafﬁnization and
antigen retrieval (Bosse et al., 2006a; Bosse et al., 2006b), the sections
were incubated with the primary antibody for 1 h at 37 °C, rinsed, and
then incubated with the secondary antibody for 1 h at 37 °C. For
immunoﬂuorescence, sections were incubated in a solution contain-
ing 4′,6-diamino-2-phenylindol dihydrochloride (DAPI, 2 μg/ml,
Molecular Probes) in PBS for 15 min at room temperature, washed
in PBS, and mounted in Mowiol mounting medium (Calbiochem). For
immunohistochemistry, biotinylated secondary antibodies were
linked to avidin-horseradish peroxidase or avidin-alkaline phospha-
tase conjugates (Vector Labs), and visualized using 3,3′-diamino
benzidine (DAB) for 2–5 min or 4-nitro blue tetrazolium chloride
(NBT)/5-bromo-4-chloro-3indolyl-phosphate (BCIP) for 20–90 min,
respectively. For selected sections, the tissue was lightly counter-
stained with methyl green.
The primary antibodies included rabbit anti-ASBT (1:500, kind
gift of Dr. P.A. Dawson, Wake Forest School of Medicine), goat anti-
FOG1 (1:200, Santa Cruz), mouse anti-GATA4 (1:400, Santa Cruz),
goat anti-GATA4 (1:400, Santa Cruz), rabbit anti-chromograninA
(1:1000, Immunostar), rabbit anti-lysozyme (1:200, Zymed), and
rabbit anti-Ki67 (1:100, Zymed). The secondary antibodies included
Alexa ﬂuor 488 anti-rabbit IgG (1:500, Invitrogen), biotinylated anti-
goat IgG (1:500, Vector Labs), and biotinylated anti-rabbit IgG (1:500,
Vector Labs).Gata4, Fog1, and Fog2 mRNA abundances were determined by real-time RT-PCR of RNA
esent single data points from individual mice. Bars indicate medians. RNA from jejunum
om ileum of 3 wild-type mice was used as a calibrator for Fog2.
Fig. 4. Asbt and Ilbp expression is induced in the Gata4 knock-in mice as compared to
het-controls. (A) Asbt and IlbpmRNA abundances were determined by real-time RT-PCR
on RNA isolated from the mid-jejunum of Gata4 knock-in mice and het-controls. Data
are represented as indicated in the legend for Fig. 3. Pooled RNA from ileum of 3 wild-
type mice was used as a calibrator. (B–E) ASBT was identiﬁed by immunoﬂuorescence
(green) for representative samples of knock-in jejunum (B), het-control jejunum (C),
wild-type jejunum (D) and wild-type ileum (E). Nuclei were counterstained with DAPI
(blue). White arrowhead indicates positive ASBT immunoﬂuorescence (C).
Fig. 5. GATA4-mediated activation pathway in absorptive enterocytes and cell lineage
markers were not signiﬁcantly different between Gata4 knock-in mice and het-controls.
The mRNAs for the GATA4-regulated activation pathway in absorptive enterocytes (Lph
and Fabp1) and for cell lineage (Math1, Muc2, Cck, Pyy) were determined by real-time
RT-PCR on RNA isolated from themid-jejunum of Gata4 knock-in mice and het-controls.
Data are represented as indicated in the legend for Fig. 3. Pooled RNA from jejunum of 3
wild-type mice was used as a calibrator for Lph, Fabp1, Math1 and Cck, whereas pooled
RNA from ileum of 3 wild-type mice was used as a calibrator for Muc2 and Pyy.
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A total of 16 knock-in and 10 het-control mice were analyzed. Due
to unequal variances for certain data sets, the median and individual
data points are presented, and statistically signiﬁcant differences,
indicated by a P-value of less than 0.05, were determined by the
nonparametric Mann–Whitney U-test. For data sets in which sta-
tistical analysis was not performed, the mean and standard deviation
are indicated.
Results
GATA4-mediated repression of Asbt gene expression occurs in
differentiated absorptive enterocytes
As previously shown (Bosse et al., 2006a), conditional, inducible
Gata4 inactivation by excision of the activation domains of GATA4
(synthesis of GATA4Δex2), results in an induction in jejunum of
absorptive enterocyte genes normally restricted to distal ileum,
including Asbt and Ilbp. Since GATA4 is expressed in both crypt andvillus epithelial cells (Bosse et al., 2006a; Divine et al., 2004; Dusing
and Wiginton, 2005; van Wering et al., 2004), it is uncertain
whether GATA4 represses ileal-speciﬁc genes in proximal small
intestine by a process that occurs in differentiated absorptive
enterocytes on villi, and/or is determined early in the differentiation
program in crypt progenitor cells. To localize the site of action for
GATA4-mediated repression of intestinal genes, the induction of Asbt
expression during the initial phases of Gata4 inactivation was
characterized. Gata4ﬂox/ﬂox mice positive for the VillinCreERT2
transgene were treated for 1 day or 2 days with tamoxifen, and
sacriﬁced 24 h after the last injection. In mid-jejunum, CRE-
mediated excision of Gata4 was complete after only one injection
of tamoxifen (Fig. 2A), and Asbt mRNA was induced (Fig. 2B).
Because of the 3-day crypt-to-villus tip cell migration time in mice
(Gordon et al., 1992), we hypothesized that if Asbt was induced
directly in differentiated absorptive enterocytes, then ASBT would
184 E. Beuling et al. / Developmental Biology 322 (2008) 179–189ﬁrst be detected in a random, patchy pattern throughout the villi.
Conversely, if Asbt was induced by a process that originated in
crypts, then it would ﬁrst appear in lower villi and migrate up the
villi over time. ASBT, not normally present in mid-jejunum (Fig. 2C)
(Dawson et al., 2003; Shneider et al., 1995), was ﬁrst detected in the
microvillus membrane of single cells scattered throughout the villi
after 1 day of Gata4 inactivation (Figs. 2D–F), and was increasingly
expressed in a patchy pattern along the length of the villi extending
to the villus tip after 2 days of Gata4 inactivation (Figs. 2G–I). ASBT
induction in the mid-jejunum of Gata4 mutant mice is shown as a
control (Fig. 2J). Although the design and outcome of this
experiment cannot rule out the possibility that a component of
GATA4-mediated Asbt repression in the jejunum is directed by
GATA4 in crypt cells, these data are consistent with the hypothesis
that GATA4 mediates Asbt repression in differentiated absorptive
enterocytes on villi.Fig. 6. FOG1 demonstrates a decreasing proximal-to-distal expression pattern in adult mouse
RT-PCR on RNA obtained from segments 1–5 fromwild-type mouse small intestine, stomach
calibrator. (B) FOG1 was identiﬁed byWestern blot analysis on crude nuclear extracts isolated
anti-FOG1 antibody (Santa Cruz) and an anti-goat IgG secondary antibody (Santa Cruz), with
an anti-β-actin antibody.Inducible VillinCreERT2-mediated recombination of the Gata4ﬂox allele in
Gata4ki/ﬂox mice results in an intestine-speciﬁc Gata4 knock-in model
FOG cofactors mediate GATA-regulated repression of speciﬁc
genes in multiple non-intestinal systems (Crispino et al., 1999;
Grass et al., 2003; Hong et al., 2005; Letting et al., 2004; Lu et al.,
1999; Roche et al., 2008; Svensson et al., 1999; Tsang et al., 1997), but
their function and expression in the small intestine is unknown. To
test the hypothesis that FOG cofactors mediate the GATA4-regulated
repression of ileal-speciﬁc absorptive enterocyte genes in the
proximal small intestine, we established Gata4ki/ﬂox, VillinCreERT2-
positive (knock-in) mice, and Gata4wt/ﬂox, VillinCreERT2-positive
heterozygous controls (het-controls) (Fig. 1). All genotypes were
conﬁrmed by PCR using primer pairs that distinguish the Gata4ki
from the Gata4ﬂox or Gata4wt alleles, as well as the Gata4ﬂox from the
Gata4ki or Gata4wt alleles (Fig. S3A).small intestine. (A) Fog1 (upper) and Fog2 (lower) mRNAswere determined by real-time
, and heart (n=3 in each group). RNA from jejunum of a wild-type mouse was used as a
from quarters I–IV (proximal-to-distal) of wild-type mouse small intestine using a goat
out (left) or with (right) an epitope-speciﬁc blocking peptide. Blots were re-probed with
Fig. 7. Fog1mRNA is expressed in a distinct crypt–villus and proximal–distal pattern in the adult mouse small intestine. In situ hybridization assays were conducted using antisense
(A–D) and sense (E–H) Fog1 probes, and images at 20× magniﬁcation are shown. Analysis of stomach (A, E), duodenum (B, F), jejunum (C, G), and ileum (D, H) reveals a generally
decreasing proximal-to-distal signal intensity with the greatest intensity localized to the base of the gastric gland (stomach) and in crypts (small intestine).
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alleles, and speciﬁc allelic expression from the Gata4ki allele in the
knock-in mice, and from the Gata4wt allele in the het-controls, RT-PCR
and cDNA sequencing was conducted on RNA samples from mid-
jejunum. The Gata4ﬂox allele, common to both knock-in and het-
control mice, was excised in jejunum but not heart after tamoxifen
treatment (Fig. S3B), verifying intestine-speciﬁc CRE-mediated exci-
sion. To distinguish expression from the Gata4ki vs. Gata4wt alleles, the
region encompassing the V217G knock-in mutation was ampliﬁed by
RT-PCR using the Ki3 and Ki4 primers (Fig. S3C). Because Ki3 hybridizes
to exon2 sequence, and because this exon is excised from the Gata4ﬂox
allele after tamoxifen treatment producing the recombined Gata4Δex2
allele, the Gata4Δex2 cDNA is not ampliﬁed. Using a nested primer
(Ki5), the knock-in or wild-type cDNA was then conﬁrmed by
sequencing (Fig. S3C). For all mice in this study, there was no evidence
of band ambiguity at the knock-in site for Gata4 knock-in mice,
verifying that CRE-mediated excision was complete.
The expression of Gata4, Fog1, and Fog2 in the knock-in mice and
het-controls was determined (Fig. 3). Because the Gata4ki, Gata4ﬂox,
and Gata4wt alleles are all under the control of the endogenous Gata4
promoter, we quantiﬁed total Gata4 mRNA abundance as the most
sensitive indicator of a possible knock-in effect on Gata4 expression.
Total Gata4 and Fog1 mRNA abundances were not signiﬁcantly
different between the two groups, but Fog2 mRNA was signiﬁcantly
lower (60%, Pb0.05) in the knock-in mice as compared to the het-
controls. Noteworthy, the cycle threshold (CT) for Fog1 was ~9 cycles
lower as compared to Fog2 indicating that Fog1 mRNA abundance is
1000-fold higher than that of Fog2. These data suggest that although
Fog2 mRNA is expressed at low levels, its abundance is dependent
on GATA4–FOG interactions.Asbt and Ilbp expression is induced in Gata4 knock-in mice
To test the hypothesis that FOG cofactors speciﬁcally mediate
GATA4-regulated repression of ileal-speciﬁc absorptive enterocyte
genes in proximal small intestine, the jejunal expression of absorptive
enterocyte target genes and lineage markers were compared
between Gata4 knock-in mice and het-controls. As shown in Fig. 4,
the mRNA abundances of Asbt and Ilbp (Fig. 4A) in jejunum of the
knock-in mice were induced 4-fold (Pb0.01) and 14-fold (Pb0.001),
respectively, compared to the het-controls, consistent with a
requirement of GATA4–FOG interactions for repression of ileal-
speciﬁc genes in the jejunum. Noteworthy, Asbt and Ilbp mRNAs,
which are known to be undetectable in wild-type mid-jejunum
(Bosse et al., 2006a; Dawson et al., 2003; Sacchettini et al., 1990;
Shneider et al., 1995), were induced in the jejunum of the het-control
mice, indicating either a heterozygous effect, or a dominant negative
effect of GATA4Δex2 on wild-type GATA4, suggesting that repression
of Asbt and Ilbp by GATA4 is dose-dependent in vivo. ASBT was highly
induced on the microvillus membrane of villus enterocytes in the
Gata4 knock-in mice (Fig. 4B), and was detected in isolated cells in
the het-controls (Fig. 4C), generally consistent with Asbt mRNA
abundances in the two groups. Undetectable expression in wild-type
jejunum (Fig. 4D) and endogenous expression in wild-type ileum
(Fig. 4E) are shown for reference.
The mRNA abundances for the GATA4-mediated activation path-
way in absorptive enterocytes (Lph and Fabp1), and for cell lineage
markers (Math1, Muc2, Cck and Pyy) did not reveal any statistically
signiﬁcant differences (Fig. 5), suggesting that GATA4–FOG interaction
is not required for GATA4-mediated activation of absorptive enterocyte
genes, or maintenance of jejunal cell lineage distribution patterns.
Fig. 8.
^
FOG1 is co-expressed with GATA4 in absorptive enterocytes on villi and in lysozyme-positive and proliferating crypt cells. Jejunal sections obtained from adult wild-type mice
were used for all immunostaining. Immunostaining for FOG1 (A) or GATA4 (B) on serial sections demonstrates that FOG1 and GATA4 are co-expressed. Nuclei (counterstained with
methyl green) of goblet cells do not stain for FOG1 (C–
^
E). Immunostaining with antibodies for FOG1 (F–
^
H) or GATA4 (I–
^
K), co-stained with chromogranin-
^
A (F–
^
K), shows that FOG1 is
expressed in the nuclei of chromogranin-
^
A positive enteroendocrine cells, but GATA4 is not. Immunostaining with antibodies for FOG1 and lysozyme (L, M) demonstrate that FOG1 is
expressed in lysozyme-positive cells. Serial sections stained for FOG1 (N) or Ki67 (O) show that FOG1 is expressed in Ki67-positive proliferating cells in crypts. Open arrowheads
indicate an absence of FOG1 or GATA4 staining; ﬁlled arrowheads indicate FOG1-positive immunostaining.
186 E. Beuling et al. / Developmental Biology 322 (2008) 179–189
187E. Beuling et al. / Developmental Biology 322 (2008) 179–189FOG1 demonstrates a decreasing proximal-to-distal expression pattern
in adult mouse small intestine
To begin to elucidate which FOG cofactor may be responsible for
mediating GATA4 function, the expression patterns of Fog1 and Fog2
were determined in the adult mouse small intestine. Fog1 mRNA
abundance demonstrated a decreasing proximal-to-distal pattern
(Fig. 6A, upper) similar to that of Gata4 (Bosse et al., 2006a; van
Wering et al., 2004). The abundance of Fog1 mRNA in proximal
duodenum (segment 1) was similar to that in stomach, but in distal
ileum (segment 5) was ~10% of that in stomach, and similar to the
low level of expression in heart. Fog2 mRNA was low proximally and
increased distally (Fig. 6A, lower), a pattern reciprocal to that of
Gata4 and Fog1. Intestinal Fog2 mRNA abundance was similar or
less than that in stomach, and ranged from 7 to 20% of that in heart.
To determine whether FOG proteins mimic their mRNA distribu-
tions, Western blot analyses were carried out. Since Fog2 mRNA
abundance was low in the small intestine (∼1000-fold less than Fog1),
and FOG2 protein could not be detected by immunohistochemistry
(data not shown), only protein patterns for FOG1 were analyzed. As
shown in Fig. 6B, a 160 kDa band corresponding to FOG1 (Cantor et al.,
2002) demonstrated a declining proximal-to-distal pattern similar to
that of its mRNA proﬁle. The 160 kDa band, as well as bandswith faster
mobilities, were speciﬁcally blocked by an epitope-speciﬁc polypep-
tide, verifying speciﬁc antigen detection. Taken together, these data
demonstrate that FOG1 has a declining proximal-to-distal expression
pattern in the adult small intestine that is similar to that of GATA4.
To deﬁne Fog1 mRNA expression at the cellular level, in situ
hybridization assays were carried out on stomach and small intestine
of wild-type mice (Fig. 7). Fog1 mRNA was highly expressed in the
stomach with the strongest signal localized to the base of the gastric
gland (Fig. 7A). Fog1 mRNA was detected throughout the small
intestine, but revealed a clear proximal-to-distal decrease in signal
intensity and cellular localization (Figs. 7B–D), corroborating the
quantitative cephalo–caudal decrease in Fog1mRNA and protein. Fog1
mRNAwas detected in crypts and villi in duodenum, crypts and lower
villi in jejunum, and only in crypts in ileum. A sense control was used
to indicate background (Figs. 7E–H).
FOG1 is co-expressed with GATA4 in absorptive enterocytes on villi, and
in lysozyme-positive and proliferating cells in the crypt of the adult
mouse small intestine
To delineate the cellular expression patterns of FOG1 in the small
intestine, and its co-localization with GATA4, immunostaining for
FOG1 and GATA4, along with lineage-speciﬁc markers, was conducted
on proximal jejunum of adult mouse small intestine. We had
previously demonstrated that GATA4 is expressed in absorptive
enterocytes on villi, and in proliferating and lysozyme-positive crypt
cells, but is not expressed in goblet or enteroendocrine cells (Bosse et
al., 2006a). Using an alkaline phosphatase substrate detection
approach, FOG1 was identiﬁed in the nuclei of epithelial cells
throughout the crypts and villi (Fig. 8A), and serial section immunos-
taining revealed co-localization with GATA4 (Fig. 8B) in both
compartments. FOG1 immunostaining could not be detected in the
nuclei of goblet cells (Figs. 8C–E), as with GATA4 (Bosse et al., 2006a),
but FOG1 immunostaining was detected in the nuclei of chromo-
graninA-positive enteroendocrine cells (Figs. 8F–H), contrasting with
the absence of GATA4 immunostaining in this lineage (Figs. 8I–K)
(Bosse et al., 2006a). FOG1 immunostaining was also detected in
lysozyme-positive (Figs. 8L, M) and proliferating (Figs. 8N,O) crypt
cells, and was thus co-localized with GATA4 in this compartment
(Bosse et al., 2006a). Taken together, these data show that FOG1 and
GATA4 are co-localized in absorptive enterocytes on villi, and in
lysozyme-positive and proliferating crypt cells of the adult mouse
small intestine, demonstrating a topographic basis for possibleinteractions. These data also reveal divergent expression in chromo-
graninA-positive enteroendocrine cells, suggesting that FOG1 has
functions in this lineage that are independent of GATA4.
Discussion
GATA4, a transcription factor expressed in the proximal small
intestine but not in the distal ileum, maintains proximal–distal
distinctions in the mature small intestine by multiple processes
involving gene repression, gene activation, and cell fate determination
(Bosse et al., 2006a). Since interactions between GATA factors and FOG
cofactors result in the repression of GATA-mediated transcriptional
activation of hematopoietic and cardiac target promoters (Crispino et
al., 1999; Grass et al., 2003; Hong et al., 2005; Letting et al., 2004; Lu et
al.,1999; Roche et al., 2008; Svensson et al.,1999; Tsang et al.,1997), we
tested the hypothesis that FOG cofactors are necessary for GATA4-
mediated repression of ileal-speciﬁc absorptive enterocyte genes in
the small intestine in vivo.We engineered a novel, inducible, intestine-
speciﬁc Gata4 knock-in model (Fig. 1), in which wild-type GATA4 is
speciﬁcally inactivated in the intestine, but a GATA4 mutant that does
not bind FOG cofactors (GATA4ki) continues to be expressed.We found
that ileal-speciﬁc genes are induced in the proximal small intestine
(Fig. 4), whereas genes restricted to proximal small intestine and cell
lineage markers are unaffected (Fig. 5), indicating that GATA4–FOG
interactions contribute speciﬁcally to the repression function of GATA4
within this organ. Furthermore, co-expression of GATA4 and FOG1 in
the nuclei of absorptive enterocytes on villi, and throughout the crypt
epithelium (Fig. 8), suggests that FOG1 mediates GATA4-regulated
repression of intestinal genes, although a role for FOG2 in this process
cannot be discounted. These ﬁndings provide the ﬁrst indication of
FOG function and expression in the mammalian small intestine.
Repression of speciﬁc genes by GATA factors is well documented
(Crispino et al., 1999; Grass et al., 2003; Letting et al., 2004; Lu et al.,
1999; Svensson et al., 1999; Tsang et al., 1997), and generally occurs by
recruitment of FOG cofactors to target gene promoters, which, in turn,
mediates recruitment of the nucleosome remodelling and histone
deacetylase (NuRD) complex leading to the deacetylation of local
histones and gene silencing (Hong et al., 2005; Roche et al., 2008). Our
data show that, GATA4 and FOG cofactors, speciﬁcally FOG1, are co-
expressed in differentiated absorptive enterocytes on villi (Fig. 8), and
are consistent with the hypothesis that GATA4 mediates Asbt
repression in differentiated absorptive enterocytes on villi rather
than by an upstream process dictated earlier in the differentiation
process in crypt progenitor cells (Fig. 2). These ﬁndings have led us to
hypothesize that GATA4 mediates Asbt repression by binding directly
to the Asbt promoter. While it is possible that an indirect pathway
within absorptive enterocytes, such as repression of another activator,
or activation of a repressor, could mediate Asbt repression, we have
previously shown that the mRNAs for known activators of Asbt,
including hepatocyte nuclear factor-alpha (HNF1α) (Shih et al., 2001),
liver receptor homolog-1 (LRH1) (Chen et al., 2003), and c-FOS (Chen
et al., 2001), are not decreased in our conditional Gata4 inactivation
model (Bosse et al., 2006a). Thus, we hypothesize that GATA4-
regulated repression of speciﬁc intestinal genes is mediated by
promoter-dependent recruitment of GATA4–FOG complexes that
may, in turn, promote histone deacetylation and gene silencing by
recruitment of the NuRD complex. This model assumes that GATA4–
FOG repression in the proximal small intestine hierarchically over-
rides activation by HNF1α, LRH1, c-FOS, or any other as yet unknown
activator of Asbt gene expression.
Our data show that while the gene repression pathway is
dependent on GATA4–FOG interactions (Fig. 4), the gene activation
pathway is independent of this interaction (Fig. 5). We and others
have previously shown using in vitro and cell culture models that
GATA4 physically associates with HNF1α and synergistically activates
the Lph and Fabp1 promoters (Divine et al., 2004; van Wering et al.,
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al., 2002). Furthermore, both Lph and Fabp1 are strongly attenuated in
intestine of mice in which Gata4 is conditionally inactivated (Bosse et
al., 2007, 2006a), or Hnf1α is knocked out (Bosse et al., 2007, 2006b).
These ﬁndings support our original hypothesis that the overlapping
expression of GATA4 and HNF1α in the intestinal epithelium,
combined with speciﬁc promoter signatures in target genes, results
in the activation of a speciﬁc subset of genes in proximal small
intestine (Krasinski et al., 2001; van Wering et al., 2004, 2002). It is
intriguing to speculate that the promoter conﬁgurations in genes
activated by GATA4–HNF1α cooperativity speciﬁcally exclude the
recruitment of GATA4–FOG complexes.
We had previously shown that conditional inactivation of Gata4
results in a signiﬁcant increase in goblet cell number in the jejunum, and
an increase in the expressionofMath1 (Bosse et al., 2006a), amediator of
secretory lineages in the intestine (Yang et al., 2001), consistent with a
jejunum-to-ileum transformation in cell fate allocation. We also
previously found in the jejunum a trend toward an increase in the
mRNA abundance of Muc2, a goblet cell marker (Specian and Oliver,
1991), and a trend toward a decease in themRNA for Cck and increase in
that for Pyy, both of which are enteroendocrine cell markers that
normally show an increasing and decreasing proximal–distal gradient
(Schonhoff et al., 2004), respectively. In the present study, we found no
evidence that FOG cofactors are required for GATA4-regulated cell fate
allocation in the intestine (Fig. 5). However, it should be noted that
jejuno-ileal differences in cell lineage composition are subtle, and that
these differences may be obscured by a gene dosage effect due to the
heterozygous nature of the controls, and thus a role for GATA4–FOG
interactions in these processes cannot be ruled out.
Both Fog1 and Fog2mRNAs are expressed in the adult mouse small
intestine, but Fog1 is more abundant (∼1000-fold), and demonstrates
a quantitative pattern that is similar to that of Gata4 (Fig. 6). In
humans, Fog1 mRNA is expressed in the proximal small intestine
(Freson et al., 2003), whereas Fog2mRNA cannot be detected (Holmes
et al., 1999), supporting the relative differential abundances of Fog1
and Fog2 mRNAs in the mouse small intestine. FOG1 and GATA4 are
co-expressed in absorptive enterocytes on villi, and throughout the
proliferating and lysozyme-positive Paneth cells in crypts (Fig. 8),
suggesting that FOG1 mediates GATA4 function. While FOG1 is
generally associated with GATA1, and FOG2 with GATA4, FOG1 was
shown to be necessary for heart development (Katz et al., 2003)
presumably reﬂecting cooperation with the GATA4/5/6 subfamily.
FOG1 is also expressed in the chromograninA-positive enteroendo-
crine cells while GATA4 is not expressed in these cells (Bosse et al.,
2006a), suggesting that FOG1 has functions in these cells that are
independent of GATA4, possibly through interaction with GATA6,
which is expressed in this lineage (Dusing and Wiginton, 2005). Fog2
mRNA is detectible in the adult mouse small intestine (Fig. 6A), and is
decreased in the Gata4 knock-in mice as compared to the het-controls
(Fig. 3), suggesting that its levels are regulated by GATA4–FOG
interactions. Although our data support a role for FOG1 in mediating
GATA4 function, we cannot rule out the possibility that FOG2, or both
FOG1 and FOG2, are required for GATA4 function in the intestine.
Correlation of our knock-in results with those of conditional Fog1 and
Fog2 single and double knockout will allow a precise determination of
FOG1 and FOG2 requirements for GATA4 function in this organ.
Thedemonstration of aGATA4–FOG requirement for gene expression
in thesmall intestineadds to thegrowing list of tissues andcell types that
require GATA–FOG interactions for normal function. In addition to the
well documented role of GATA1–FOG1 interactions in hematopoiesis
(Cantor and Orkin, 2005), GATA4–FOG interaction is required for
coronary vasculature initiation, cardiac morphogenesis and valve
formation during cardiogenesis (Crispino et al., 2001), differentiation of
precursors into XY-speciﬁc Sertoli cells during gonad development
(Tevosian et al., 2002), and epithelial–mesenchymal signaling during
stomach development (Jacobsen et al., 2005). While these studies allhighlight the critical roles of GATA4–FOG interactions for speciﬁc aspects
of embryonic development, our study, due to the inducible nature of our
model, is the ﬁrst to demonstrate a role for GATA4–FOG interactions in
adult intestine. Taken together, these studies underscore the diverse
nature of GATA4–FOG functions, including morphogenesis, cell fate
determination, and maintenance of terminal differentiation.
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